DI IASIO, Maria Grazia
 Distribuzione geografica
Continente #
NA - Nord America 3.701
AS - Asia 1.764
EU - Europa 875
SA - Sud America 311
AF - Africa 33
OC - Oceania 4
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.690
Nazione #
US - Stati Uniti d'America 3.643
SG - Singapore 676
CN - Cina 467
BR - Brasile 252
VN - Vietnam 222
UA - Ucraina 184
DE - Germania 165
GB - Regno Unito 127
HK - Hong Kong 120
TR - Turchia 112
IT - Italia 96
FI - Finlandia 64
SE - Svezia 54
FR - Francia 52
RU - Federazione Russa 40
IN - India 35
CA - Canada 28
JP - Giappone 28
NL - Olanda 27
AR - Argentina 24
BD - Bangladesh 20
MX - Messico 18
ID - Indonesia 17
PL - Polonia 16
BE - Belgio 13
IQ - Iraq 10
PK - Pakistan 10
ZA - Sudafrica 10
ES - Italia 9
CO - Colombia 7
EC - Ecuador 7
LT - Lituania 7
IL - Israele 6
PY - Paraguay 6
VE - Venezuela 6
CL - Cile 5
MA - Marocco 5
UZ - Uzbekistan 5
AU - Australia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
IR - Iran 4
JO - Giordania 4
PH - Filippine 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
JM - Giamaica 3
RS - Serbia 3
TN - Tunisia 3
AZ - Azerbaigian 2
CH - Svizzera 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
TG - Togo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AQ - Antartide 1
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.690
Città #
Ashburn 416
Fairfield 408
Singapore 395
Woodbridge 385
Houston 235
Jacksonville 199
San Jose 195
Chandler 169
Beijing 158
Ann Arbor 140
Seattle 137
Santa Clara 133
Wilmington 122
Hong Kong 119
Cambridge 104
Ho Chi Minh City 84
Izmir 66
New York 61
Los Angeles 56
Hanoi 54
Dallas 53
Nanjing 47
Munich 41
Princeton 40
San Diego 39
Lauterbourg 33
Ferrara 32
Boardman 28
Tokyo 28
São Paulo 25
Shanghai 22
Orem 21
Brooklyn 20
Falls Church 18
Council Bluffs 17
Milan 17
Nanchang 16
Tianjin 16
Turku 16
Montreal 15
Amsterdam 14
Buffalo 14
Mexico City 14
Changsha 13
London 13
Poplar 13
Warsaw 13
Brussels 12
Hefei 12
Shenyang 12
Denver 11
Hebei 11
Helsinki 11
San Mateo 11
Chennai 10
Dearborn 10
Haiphong 10
Chicago 9
Da Nang 9
Atlanta 8
Manchester 8
Columbus 7
Jakarta 7
Jiaxing 7
Mumbai 7
Norwalk 7
Orange 7
Stockholm 7
Zhengzhou 7
Ankara 6
Boston 6
Dronten 6
Jinan 6
Philadelphia 6
The Dalles 6
Verona 6
Washington 6
Auburn Hills 5
Augusta 5
Baghdad 5
Belo Horizonte 5
Bremen 5
Guarulhos 5
Hải Dương 5
Johannesburg 5
Kunming 5
Leawood 5
Medellín 5
Mountain View 5
Porto Alegre 5
San Francisco 5
Amman 4
Bologna 4
Brno 4
Bắc Ninh 4
Delhi 4
Dhaka 4
Frankfurt am Main 4
New Delhi 4
Ninh Bình 4
Totale 4.628
Nome #
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 248
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 246
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 228
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 212
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 210
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 207
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 206
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 205
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 205
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 202
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 195
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 195
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 188
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 184
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 176
Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients 173
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 172
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 171
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 165
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 161
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 159
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to Nutlin-3 induces a characteristic gene expression profile, which correlates with Nutlin-3-mediated cytotoxicity 158
The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells 151
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies 151
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 149
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 145
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 143
Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region 143
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 143
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 116
Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias 115
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 110
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 109
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 108
null 100
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 99
null 98
null 98
null 97
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 90
null 89
null 83
null 69
null 55
Totale 6.727
Categoria #
all - tutte 27.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021118 0 0 0 0 0 0 0 0 0 0 89 29
2021/2022449 12 60 27 23 22 20 33 22 12 27 52 139
2022/2023398 41 20 20 41 66 57 11 32 54 7 28 21
2023/2024149 23 13 7 3 6 29 8 17 1 4 2 36
2024/2025895 23 21 64 44 122 50 44 38 187 65 135 102
2025/20262.299 259 172 208 314 348 179 243 98 209 256 13 0
Totale 6.727